Posts by BORN Ontario

The Risks of Preeclampsia in Pregnancy
Preeclampsia is a common and dangerous complication of pregnancy that causes high blood pressure and excess protein in urine.

February 2024 Update 
Our investigation is complete, and we have shared information with those affected through public channels.  We deeply regret any inconvenience that this incident has caused. If you have questions, please contact us at privacy@bornontario.ca

October 2nd - 6th is Sonography Week  - 5 days to recognize and celebrate the important contributions of sonographers in Canada.

Imagine a job where you’re required to make precise measurements (to the tenth of a millimeter) and if they’re not accurate a pregnant person may be misinformed about their baby’s chance of having Down Syndrome.

Prenatal Screening Ontario (PSO) plays a vital role in supporting informed decision-making and improving care for pregnant individuals across the province. By collecting and analyzing data on prenatal screening outcomes, PSO helps healthcare providers and families understand how well screening tests perform and how services can be optimized. This data-driven approach not only enhances clinical practice but also informs policy changes—ensuring that prenatal screening in Ontario remains safe, effective, and responsive to the needs of the population.

This week we're celebrating the sonography profession and the important role sonographers play in providing quality healthcare to Canadians. Sonographers help diagnose disease and injury, monitor health, and guide medical treatment.

Prenatal Screening Ontario (PSO) offers resources and point of care tools to support sonographers in performing high-quality nuchal translucency (NT) and crown-rump length (CRL) measurements. 

Data from the BORN Information System was recently used to investigate the association of COVID-19 vaccination in pregnancy with risk of preterm birth, small for gestational age at birth, and stillbirth.

This study, published in the British Medical Journal, was supported by funding from the Public Health Agency of Canada, through the Vaccine Surveillance Reference Group and the COVID-19 Immunity Task Force.